Activated astrocytes have been shown to markedly overexpress S100B, also during AD [8,17], and most of these astrocytes overexpressing S100B are closely associated with diffuse or neuritic Aβ plaques, thus being regarded as playing a significant role in pathogenic processes [18,19,20]. This evidence concerns the gene S100B and Alzheimer disease.